Table 2. Analysis of extraintestinal manifestations (EIM).
EIM | Non-EIM group (%) | EIM group (%) | N (%) |
---|---|---|---|
Rash | 0 (0.0) | 7 (22.6) | 7 (2.6) |
Oral aphthous ulcers | 0 (0.0) | 10 (32.3) | 10 (3.7) |
Arthritis | 0 (0.0) | 14 (45.2) | 14 (5.2) |
Primary sclerosing cholangitis (PSC) | 0 (0.0) | 2 (6.5) | 2 (0.7%) |
Iritis | 0 (0.0) | 1 (3.2) | 1 (0.4) |
Vasculitis | 0 (0.0) | 1 (3.2) | 1 (0.4) |
Ankylosing spondylitis | 0 (0.0) | 1 (3.2) | 1 (0.4) |
Autoimmune hepatitis | 0 (0.0) | 1 (3.2) | 1 (0.4) |
Glomerulonephritis | 0 (0.0) | 2 (6.5) | 2 (0.7) |